Artifact Gallery

Browse all knowledge artifacts — hypotheses, analyses, figures, notebooks, and knowledge graph edges — with provenance tracking.

All 📖 Wiki Page (18447)📊 Figure (8106)📦 Open Question (7838)🕸 Kg Edge (7650)🖼 Paper Figure (3852)📓 Notebook (796)📄 Paper (654)🧫 Experiment (647)🧪 Hypothesis (200)🔬 Analysis (194)📦 Evidence (50)🧬 Protein Design (23)📦 Rigor Score Card (22)📈 Dashboard (12)🗃 Dataset (9)🧠 Model (9)📦 Capsule (6)🎨 Ai Image (4)📦 Landscape Analysis (4)📋 Tabular Dataset (4)📜 Authored Paper (3)📦 Test Version (2)📦 Dashboard Snapshot (2)💻 Code (1)📦 Debate Analysis (1)

Showing 30 of 7,838 open question artifacts

Sort: QualityNewest Most Linked Type

View: ☰ ▦

📦

Can NPY/AgRP-targeting therapies improve metabolic outcomes in AD/PD without dis...

open question

2026-04-25 by backfill_open_questions 50%

cell

📦

Does early tau or α-synuclein pathology in the hypothalamus directly dysregulate...

open question

2026-04-25 by backfill_open_questions 50%

cell

📦

Disease modification**: Can interventions begun early in disease course prevent ...

open question

2026-04-25 by backfill_open_questions 50%

proteins

📦

Combination therapies**: What therapeutic combinations will prove most effective...

open question

2026-04-25 by backfill_open_questions 50%

proteins

📦

Biomarker development**: Can we identify robust biomarkers for patient stratific...

open question

2026-04-25 by backfill_open_questions 50%

proteins

📦

Therapeutic window**: What level of protein reduction would be therapeutic witho...

open question

2026-04-25 by backfill_open_questions 50%

proteins

📦

Mechanism of mutation pathogenesis**: How do specific mutations impair UBQLN2 fu...

open question

2026-04-25 by backfill_open_questions 50%

proteins

📦

Mechanistic understanding**: How does alpha-synuclein spread through autonomic n...

open question

2026-04-25 by backfill_open_questions 50%

other

📦

Biomarker validation**: Can STMN1 be clinically useful?

open question

2026-04-25 by backfill_open_questions 50%

genes

📦

Therapeutic window**: When to intervene for maximum benefit?

open question

2026-04-25 by backfill_open_questions 50%

genes

📦

Disease staging**: What is STMN1's role at different disease stages?

open question

2026-04-25 by backfill_open_questions 50%

genes

📦

Cell-type specificity**: How does STMN1 function differ across neuron types?

open question

2026-04-25 by backfill_open_questions 50%

genes

📦

What is the role of SORCS2 in tau pathology propagation?

open question

2026-04-25 by backfill_open_questions 50%

genes

📦

How do SORCS2 rare variants contribute to disease pathogenesis?

open question

2026-04-25 by backfill_open_questions 50%

genes

📦

What is the relationship between SORCS2 and other AD risk genes?

open question

2026-04-25 by backfill_open_questions 50%

genes

📦

Can SORCS2 be targeted therapeutically without adverse effects?

open question

2026-04-25 by backfill_open_questions 50%

genes

📦

How exactly does SORCS2 modulate APP processing?

open question

2026-04-25 by backfill_open_questions 50%

genes

📦

How can LDL Receptor, Cholesterol Metabolism signals be standardized across coho...

open question

2026-04-25 by backfill_open_questions 50%

researchers

Loading more artifacts...

Artifact Gallery

Can NPY/AgRP-targeting therapies improve metabolic outcomes in AD/PD without dis...

Does early tau or α-synuclein pathology in the hypothalamus directly dysregulate...

Disease modification**: Can interventions begun early in disease course prevent ...

Combination therapies**: What therapeutic combinations will prove most effective...

Biomarker development**: Can we identify robust biomarkers for patient stratific...

Therapeutic window**: What level of protein reduction would be therapeutic witho...

Mechanism of mutation pathogenesis**: How do specific mutations impair UBQLN2 fu...

How does autophagy change during normal aging versus neurodegeneration?

What is the relationship between autophagy and apoptosis in neurodegeneration?

Can we develop neuron-specific autophagy modulators?

How is autophagy regulated in different neuronal compartments?

What determines the specificity of cargo recognition?

Mechanistic understanding**: How does amyloid disrupt DMN function?

Disease specificity**: Why do certain mutations cause retina-specific disease?

Coordinate regulation**: How is activity coupled to other spliceosomal steps?

Substrate recognition**: How does SNRNP200 select specific RNA substrates?

Therapeutic windows**: What is the therapeutic index of spliceosome modulators?

Cell type vulnerability**: Why are certain neurons more susceptible?

Mechanism specificity**: How does SNRNP200 select specific substrates?

Mechanistic understanding**: How does alpha-synuclein spread through autonomic n...

Biomarker validation**: Can STMN1 be clinically useful?

Therapeutic window**: When to intervene for maximum benefit?

Disease staging**: What is STMN1's role at different disease stages?

Cell-type specificity**: How does STMN1 function differ across neuron types?

What is the role of SORCS2 in tau pathology propagation?

How do SORCS2 rare variants contribute to disease pathogenesis?

What is the relationship between SORCS2 and other AD risk genes?

Can SORCS2 be targeted therapeutically without adverse effects?

How exactly does SORCS2 modulate APP processing?

How can LDL Receptor, Cholesterol Metabolism signals be standardized across coho...